{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:51:12Z","timestamp":1788299472094,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a serious health problem, and recent evidence indicates that gut microbiota plays a key role in its development. It is known that 2-oleoyl glycerol (2-OG) produced by the gut microbiota is associated with hepatic fibrosis, but it is not known whether this metabolite is involved in the development of hepatic steatosis. The aim of this study was to evaluate how a high-fat\u2013sucrose diet (HFS) increases 2-OG production through gut microbiota dysbiosis and to identify whether this metabolite modifies hepatic lipogenesis and mitochondrial activity for the development of hepatic steatosis as well as whether a combination of functional foods can reverse this process. Wistar rats were fed the HFS diet for 7 months. At the end of the study, body composition, biochemical parameters, gut microbiota, protein abundance, lipogenic and antioxidant enzymes, hepatic 2-OG measurement, and mitochondrial function of the rats were evaluated. Also, the effect of the consumption of functional food with an HFS diet was assessed. In humans with MASLD, we analyzed gut microbiota and serum 2-OG. Consumption of the HFS diet in Wistar rats caused oxidative stress, hepatic steatosis, and gut microbiota dysbiosis, decreasing \u03b1-diversity and increased Blautia producta abundance, which increased 2-OG. This metabolite increased de novo lipogenesis through ChREBP and SREBP-1. 2-OG significantly increased mitochondrial dysfunction. The addition of functional foods to the diet modified the gut microbiota, reducing Blautia producta and 2-OG levels, leading to a decrease in body weight gain, body fat mass, serum glucose, insulin, cholesterol, triglycerides, fatty liver formation, and increased mitochondrial function. To use 2-OG as a biomarker, this metabolite was measured in healthy subjects or with MASLD, and it was observed that subjects with hepatic steatosis II and III had significantly higher 2-OG than healthy subjects, suggesting that the abundance of this circulating metabolite could be a predictor marker of hepatic steatosis.<\/jats:p>","DOI":"10.3390\/nu16162594","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T08:42:28Z","timestamp":1723020148000},"page":"2594","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatic Steatosis Can Be Partly Generated by the Gut Microbiota\u2013Mitochondria Axis via 2-Oleoyl Glycerol and Reversed by a Combination of Soy Protein, Chia Oil, Curcumin and Nopal"],"prefix":"10.3390","volume":"16","author":[{"given":"M\u00f3nica","family":"S\u00e1nchez-Tapia","sequence":"first","affiliation":[{"name":"Departamento de Fisiolog\u00eda de la Nutrici\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6583-8072","authenticated-orcid":false,"given":"Sandra","family":"Tob\u00f3n-Cornejo","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda de la Nutrici\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia G.","family":"Noriega","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda de la Nutrici\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-3526","authenticated-orcid":false,"given":"Natalia","family":"V\u00e1zquez-Manjarrez","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda de la Nutrici\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0495-486X","authenticated-orcid":false,"given":"Diana","family":"Couti\u00f1o-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda de la Nutrici\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Granados-Portillo","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda de la Nutrici\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice M.","family":"Rom\u00e1n-Calleja","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Ru\u00edz-Marg\u00e1in","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-4477","authenticated-orcid":false,"given":"Ricardo U.","family":"Mac\u00edas-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Departamento de Gastroenterolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1292-1312","authenticated-orcid":false,"given":"Armando R.","family":"Tovar","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda de la Nutrici\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-0984","authenticated-orcid":false,"given":"Nimbe","family":"Torres","sequence":"additional","affiliation":[{"name":"Departamento de Fisiolog\u00eda de la Nutrici\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, M\u00e9xico City 14080, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.bbadis.2014.08.004","article-title":"Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?","volume":"1842","author":"Gruben","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.3390\/nu7115475","article-title":"The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis","volume":"7","author":"Saponaro","year":"2015","journal-title":"Nutrients"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"San-Millan, I. (2023). The Key Role of Mitochondrial Function in Health and Disease. Antioxidants, 12.","DOI":"10.3390\/antiox12040782"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Quigley","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lei, L., Zhao, N., Zhang, L., Chen, J., Liu, X., and Piao, S. (2022). Gut microbiota is a potential goalkeeper of dyslipidemia. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.950826"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1038\/s41467-023-41074-3","article-title":"The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis","volume":"14","author":"Schoeler","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jn\/134.3.522","article-title":"Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats","volume":"134","author":"Ascencio","year":"2004","journal-title":"J. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2000532","DOI":"10.1002\/mnfr.202000532","article-title":"Antibiotic Treatment Reduces the Health Benefits of Soy Protein","volume":"64","author":"Torres","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.arcmed.2011.10.004","article-title":"Dietary type and amount of fat modulate lipid metabolism gene expression in liver and in adipose tissue in high-fat diet-fed rats","volume":"42","author":"Tovar","year":"2011","journal-title":"Arch. Med. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Shao, W., Yu, Z., Chiang, Y., Yang, Y., Chai, T., Foltz, W., Lu, H., Fantus, I.G., and Jin, T. (2012). Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0028784"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Sanchez-Tapia, M., Aguilar-Lopez, M., Perez-Cruz, C., Pichardo-Ontiveros, E., Wang, M., Donovan, S.M., Tovar, A.R., and Torres, N. (2017). Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat\/sucrose diet. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-05096-4"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/cc1548","article-title":"Statistics review 5: Comparison of means","volume":"6","author":"Whitley","year":"2002","journal-title":"Crit. Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/jn\/123.11.1939","article-title":"AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet","volume":"123","author":"Reeves","year":"1993","journal-title":"J. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1083\/jcb.43.3.506","article-title":"High-yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study","volume":"43","author":"Berry","year":"1969","journal-title":"J. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lopez-Salazar, V., Tapia, M.S., Tobon-Cornejo, S., Diaz, D., Aleman-Escondrillas, G., Granados-Portillo, O., Noriega, L., Tovar, A.R., and Torres, N. (2021). Consumption of soybean or olive oil at recommended concentrations increased the intestinal microbiota diversity and insulin sensitivity and prevented fatty liver compared to the effects of coconut oil. J. Nutr. Biochem., 94.","DOI":"10.1016\/j.jnutbio.2021.108751"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., and Huttenhower, C. (2011). Metagenomic biomarker discovery and explanation. Genome Biol., 12.","DOI":"10.1186\/gb-2011-12-s1-p47"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41467-023-35861-1","article-title":"Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: How is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G.A., Beguinot, F., and Miele, C. (2019). Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092358"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hrncir, T., Hrncirova, L., Kverka, M., Hromadka, R., Machova, V., Trckova, E., Kostovcikova, K., Kralickova, P., Krejsek, J., and Tlaskalova-Hogenova, H. (2021). Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. Microorganisms, 9.","DOI":"10.3390\/microorganisms9050957"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","article-title":"The role of the gut microbiome in chronic liver disease: The clinical evidence revised","volume":"1","author":"Schwenger","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yang, C., Xu, J., Xu, X., Xu, W., Tong, B., Wang, S., Ji, R., Tan, Y., and Zhu, Y. (2023). Characteristics of gut microbiota in patients with metabolic associated fatty liver disease. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-37163-4"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_28","unstructured":"Ross Watson, R., Preedy, V.R., and Zibadi, S. (2018). Manipulation of mitochondrial function by polyphenols for new treatment strategies. Polyphenols: Mechanisms of Action in Human Health and Disease, Academic Press."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Koudoufio, M., Desjardins, Y., Feldman, F., Spahis, S., Delvin, E., and Levy, E. (2020). Insight into Polyphenol and Gut Microbiota Crosstalk: Are Their Metabolites the Key to Understand Protective Effects against Metabolic Disorders?. Antioxidants, 9.","DOI":"10.3390\/antiox9100982"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"20420188231160394","DOI":"10.1177\/20420188231160394","article-title":"Non-pharmacological management options for MAFLD: A practical guide","volume":"14","author":"Stefano","year":"2023","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cai, T., Song, X., Xu, X., Dong, L., Liang, S., Xin, M., Huang, Y., Zhu, L., Li, T., and Wang, X. (2024). Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: A narrative review with a focus on the modulation of the gut microbiota. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1323261"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2006.06.008","article-title":"Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis","volume":"4","author":"Uyeda","year":"2006","journal-title":"Cell Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI25256","article-title":"Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation","volume":"115","author":"Dentin","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.6061\/clinics\/2018\/e150","article-title":"\u03b1-Linolenic acid prevents hepatic steatosis and improves glucose tolerance in mice fed a high-fat diet","volume":"73","author":"Goncalves","year":"2018","journal-title":"Clinics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1055\/a-0586-4711","article-title":"Therapeutic Perspectives on Chia Seed and Its Oil: A Review","volume":"84","author":"Parker","year":"2018","journal-title":"Planta Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3138\/canlivj-2023-0022","article-title":"Effects of curcumin in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"7","author":"Malik","year":"2024","journal-title":"Can. Liver J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3945\/an.115.009423","article-title":"Potential for dietary omega-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer","volume":"6","author":"Jump","year":"2015","journal-title":"Adv. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.clnu.2010.06.001","article-title":"The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease","volume":"30","author":"Shapiro","year":"2011","journal-title":"Clin. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4597246","DOI":"10.1155\/2016\/4597246","article-title":"Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease","volume":"2016","author":"Oliveira","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/16\/2594\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:31:09Z","timestamp":1760110269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/16\/2594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":40,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["nu16162594"],"URL":"https:\/\/doi.org\/10.3390\/nu16162594","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}